Instapath Inc.
PrivateLast Round
Grant
Mar 1, 2021
Est. Valuation
$2.14M
Total Funding Raised
$6.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Instapath Inc. is a medical technology company that develops microscopy systems for rapid, slide-free digital pathology to enable faster cancer diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Instapath Inc. Comparables
Compare Instapath Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Histolix, Inc. | 90% | |
| Invenio Imaging | 86% | |
| MUSE Microscopy, Inc. | 86% |
Instapath Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2021 | ||||
| Seed | Sep 17, 2019 | ||||
| Seed | Mar 18, 2019 | ||||
| Grant | Feb 21, 2019 | ||||
| Grant | Jul 1, 2018 | ||||
Accelerator | Apr 1, 2018 |
Key People
Founding team and executive leadership
Instapath Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention & Research Institute of Texas | Grant |
| Texas Medical Center | Seed, Accelerator |
| Draper Associates | Seed |
| Y Combinator | Seed, Grant |
| Johnson & Johnson Innovation - JLABS | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 68% MoM.
- Jun 19, 2026
Monthly visitors increased 75% MoM, from 285 to 498.
Instapath Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Instapath Inc.'s valuation, stock price, and market status.
Is Instapath Inc. a public or private company?
Instapath Inc. is a private company.
What is the current stock price of Instapath Inc.?
Instapath Inc. is a private company, so its shares have no public market price. Caplight tracks Instapath Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Instapath Inc. worth (valuation)?
Instapath Inc.'s valuation is estimated at $2.1M based on funding round data.
Can I buy Instapath Inc. stock?
Instapath Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Instapath Inc.'s last funding round?
Instapath Inc.'s most recent funding round was Grant on March 1, 2021.
Who are the main investors in Instapath Inc.?
Key investors in Instapath Inc. include Cancer Prevention & Research Institute of Texas, Texas Medical Center, Draper Associates, Y Combinator, National Science Foundation.
Will Instapath Inc. IPO soon?
No public IPO plans have been announced for Instapath Inc..
How can I track Instapath Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Instapath Inc.'s shares on secondary markets.